tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Turkaly, 161 are a BUY (92.53%), 12 are a HOLD (6.9%), 1 are a SELL (0.57%).
Analyst David Turkaly, carries an average stock price target met ratio of 33.02% that have a potential upside of 29.38% achieved within 231 days. Previously, David Turkaly worked at JMP.
David Turkaly’s has documented 333 price targets and ratings displayed on 22 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on SYK, Stryker at 19-Dec-2025.
Analyst best performing recommendations are on STIM (NEURONETICS).
The best stock recommendation documented was for STIM (NEURONETICS) at 8/14/2024. The price target of $3 was fulfilled within 167 days with a profit of $2.17 (261.45%) receiving and performance score of 15.66.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 20-May-2022
$6
$1.98 (49.25%)
$17
1 months 15 days ago
(16-Dec-2025)
0/3 (0%)
$2.21 (58.31%)
Hold Since 24-May-2023
$8
$3.98 (99.00%)
2 months 19 days ago
(12-Nov-2025)
3/4 (75%)
$4 (100.00%)
243
Buy Since 29-Jan-2021
$4.5
$0.48 (11.94%)
$3
2 years 5 months 20 days ago
(11-Aug-2023)
14/16 (87.5%)
$-0.55 (-10.89%)
297
Buy Since 08-Dec-2022
$9
$4.98 (123.88%)
$6
2 years 7 months 16 days ago
(15-Jun-2023)
2/3 (66.67%)
$2.05 (29.50%)
81
Which stock is David Turkaly is most bullish on?
Which stock is David Turkaly is most reserved on?
What Year was the first public recommendation made by David Turkaly?
